Evaluation of STK17B As a Cancer Immunotherapy Target Utilizing Highly Potent and Selective Small Molecule Inhibitors
FRONTIERS IN IMMUNOLOGY(2024)
Key words
DRAK2,STK17B,immunotherapy,small molecule inhibitors,T cells,kinase
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined